SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000827809-17-000021
Filing Date
2017-04-13
Accepted
2017-04-13 16:34:04
Documents
3
Period of Report
2017-04-11
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K novelion8-kapril112017.htm 8-K 36496
2 EXHIBIT 16.1 letterfromdeloittellp.htm EX-16.1 5125
3 dt14.jpg GRAPHIC 21496
  Complete submission text file 0000827809-17-000021.txt   67362
Mailing Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5 6047077000
NOVELION THERAPEUTICS INC. (Filer) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17082 | Film No.: 17761000
SIC: 2834 Pharmaceutical Preparations